YY/T 0811-2021Extensively irradiation-crosslinked ultra-high molecular weight polyethylene fabricated forms for surgical implant applications (English PDF)
外科植入物用大剂量辐射交联超高分子量聚乙烯制品
This is a limited preview
Buy now to download the full PDF (23 pages)
Need quotation for your management?
Get a formal quotation for YY/T 0811-2021 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
September 6, 2021
Implementation date
September 1, 2022
Scope
YY/T 0811-2021 is the English-translated version of 外科植入物用大剂量辐射交联超高分子量聚乙烯制品.
YY/T 0811-2021 is the Chinese pharmaceutical industry standard for extensively irradiation-crosslinked ultra-high molecular weight polyethylene in the forms used for surgical implants, the material of the bearing surfaces of joint replacements.
It sets the requirements and the test methods for the crosslinked material: the resin it starts from under GB/T 19701.1, the irradiation and the thermal treatment that follow, the degree of crosslinking, the oxidation and the free radical content, the density, the mechanical properties and the wear behaviour, together with what the manufacturer must declare about the process.
It replaces YY/T 0811-2010, was issued on 6 September 2021 and has applied since 1 September 2022.
Found what you need?
Document preview — YY/T 0811-2021
National Standard of the People's Republic of China
- Replacing
- YY/T 0811-2010
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative references4
- 3 Terms and definitions6
- 4 Sampling6
- 5 Relevant requirements for extensively crosslinked UHMWPE products6
- 6 Biocompatibility8
- Annex A (informative) Basic principle9
- Bibliography11
Foreword
This Standard was drafted in accordance with the rules given in GB/T 1.1-2009. This Standard replaces YY/T 0811-2010 "Standard guide for extensively irradiation.
Crosslinked ultra-high molecular weight polyethylene fabricated forms for surgical implant applications". Compared with YY/T 0811-2010, in addition to the editorial modifications, the main technical changes in this Standard are as follows.
-- Add the requirements for modulus of elasticity (see Table 1 of this Edition);
1 Scope
This Standard specifies relevant requirements and test methods for irradiation- crosslinked (extensively crosslinked) ultra-high molecular weight polyethylene fabricated (UHMWPE) forms for surgical implant applications.
This Standard is applicable to pure resin powder required by GB/T 19701.1 or extensively irradiation-crosslinked UHMWPE products produced by molding compounds required by GB/T 19701.2.This Standard is only applicable to UHMWPE products that have been extensively irradiated by gamma rays and electron beam ionizing radiation sources.
This Standard does not apply to UHMWPE that has only been treated with gas plasma, ethylene oxide or ionizing radiation with a dose of less than 40kGy, that is, materials that have undergone routine sterilization only.
NOTE 1.The exact relationship between the mechanical properties of the above articles and the in vivo performance has not been established. Although scientists are devoted to the study of the relationship between polymer structure, polymer properties and polymer design, the above relationship has not been satisfactorily explained. The following mechanical tests are commonly used to assess the repeatability of manufacturing procedures and are suitable for comparative studies of different materials.
NOTE 2.The following warning text applies only to the test method part of Chapter 5: This Standard does not attempt to describe all the safety issues involved, even those related to its use. It is the responsibility of the user of this Standard to establish appropriate safety and operating practices, and to clarify the applicability of regulatory limitations prior to application.
2 Normative references
The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies.
GB/T 16886.1, Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process
GB/T 16886.2, Biological evaluation of medical devices -- Part 2: Animal welfare requirements
GB/T 16886.3, Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
GB/T 16886.4, Biological evaluation of medical devices -- Part 4: Selection of tests for interactions with blood
GB/T 16886.5, Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
GB/T 16886.6, Biological evaluation of medical devices -- Part 6: Tests for local effects after implantation
GB/T 16886.7, Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals
GB/T 16886.9, Biological evaluation of medical devices -- Part 9: Framework for identification and quantification of potential degradation products
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
3.1 UHMWPE fabricated form
UHMWPE of any shape made of pure polymer powder for surgical implants before crosslinking, packaging and sterilization.
3.3 Ionizing radiation
gamma rays or high-energy electron radiation.
3.4 Crosslinking
The process of generating chemical bonds between UHMWPE molecular chains by ionizing radiation.
4 Sampling
If applicable, each batch of powder and products shall be determined according to the requirements of this Standard.
5 Relevant requirements for extensively crosslinked UHMWPE products
5.1 Requirements for synthetics
The powder and molding compound for manufacturing extensively crosslinked UHMWPE materials shall meet the requirements of GB/T 19701.1 and GB/T 19701.2.
5.2 Physical requirements
5.2.3 Table 2 (Mechanical and physical evaluation, Part 2) lists the suitable test items and corresponding test methods for extensively crosslinked UHMWPE. Other test items, such as electron spin resonance, may also be considered based on literature and theoretical analysis (see Annex A).
5.2.4 It is recommended that functional testing based on simulated clinical functions and known failure modes be considered for extensively crosslinked UHMWPE end product components.
5.2.1 There are many production methods for extensively crosslinked
UHMWPE materials, so different manufacturers of this material have developed their own proprietary production methods and processes.
6 Biocompatibility
The results of long-term clinical trial studies show that the biological reactions that occur when using this material are at an acceptable level.
Annex A (informative)
Basic principle A.1 This standard aims to provide the minimum necessary test methods for determining the physical, chemical and mechanical properties of radiation extensively crosslinked UHMWPE materials for orthopedic or spinal implants.
A.2 One of the purposes of this Standard is to provide guidance to regulatory authorities and surgical implant manufacturers through a set of standard test methods for determining the characteristics of extensively crosslinked UHMWPE materials.
A.3 Even though it is now possible to identify test methods for characterizing extensively crosslinked UHMWPE, it is still not possible to specify acceptable minimum values for each test method. Because in most of the above-mentioned test methods, the correlation between the measured properties of the material and the clinical performance is currently unknown. Therefore, material manufacturers are required to formulate minimum standards for the production process of their extensively crosslinked UHMWPE materials. At the same time, use the test methods provided by this Standard to verify the production process.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 23 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 16886.1Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- GB/T 16886.2Biological evaluation of medical devices - Part 2: Animal welfare requirements
- GB/T 16886.3Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- GB/T 16886.4Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood
- GB/T 16886.5Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
- GB/T 16886.6Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
Similar standards
Editions of YY/T 0811
| Edition | Title | Revision | Status |
|---|---|---|---|
| YY/T 0811-2021 | Extensively irradiation-crosslinked ultra-high molecular weight polyethylene fabricated forms for surgical implant applications | current edition | Current |
| YY/T 0811-2010 | Extensively irradiation-crosslinked ultra-high molecular weight polyethylene fabricated forms for surgical implant applications | previous edition | Superseded |
This page sells the current edition, YY/T 0811-2021. Earlier editions are listed for reference only.
How to Download YY/T 0811-2021
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.1-2022 — Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
GB/T 16886.2-2011 — Biological evaluation of medical devices -- Part 2: Animal welfare requirements
GB/T 16886.2-2026 — Biological evaluation of medical devices - Part 2: Animal welfare requirements
Secure payment via Stripe
Payments accepted
YY/T 0811-2021
$150.00